Viewing Study NCT03269994


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2026-01-27 @ 6:25 AM
Study NCT ID: NCT03269994
Status: COMPLETED
Last Update Posted: 2025-10-21
First Post: 2017-08-30
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 17-418
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None UNKNOWN View
None OTHER View
None UNKNOWN View
None OTHER View
None UNKNOWN View
None OTHER View
None UNKNOWN View
None UNKNOWN View
None OTHER View
None OTHER View
None UNKNOWN View
None UNKNOWN View
None OTHER View
None OTHER View
None UNKNOWN View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None UNKNOWN View
None OTHER View
None UNKNOWN View